InvestorsHub Logo

Whalatane

07/20/20 11:23 AM

#233746 RE: DewDiligence #233742

Thx Dew. In your opinion .....how does this compare to Moderna’s data ......I have small positions in both .
Kiwi

DewDiligence

07/22/20 10:32 AM

#233792 RE: DewDiligence #233742

PFE/BNTX—US government orders $1.95B of COVID-19 vaccine—100M doses @$19.95/dose—with option to acquire additional 500M doses at the same price:

https://www.businesswire.com/news/home/20200722005438/en

Pfizer…and BioNTech SE…today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021.

Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 vaccine candidate jointly developed by Pfizer and BioNTech, after Pfizer successfully manufactures and obtains approval or emergency use authorization from U.S. Food and Drug Administration (FDA).

The U.S. government will pay the companies $1.95 billion upon the receipt of the first 100 million doses, following FDA authorization or approval. The U.S. government also can acquire up to an additional 500 million doses.

Americans will receive the vaccine for free consistent with U.S. government’s commitment for free access for COVID-19 vaccines.

… If the ongoing studies are successful, Pfizer and BioNTech expect to be ready to seek Emergency Use Authorization or some form of regulatory approval as early as October 2020.

The companies currently expect to manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial.

PFE is +2% and BNTX is +7% as I’m typing.